Clinical Trial

A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis

Name: A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis — clinical trial record (NCT06406205)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the efficacy of QL1074 compared with placebo in achieving renal response after 52 weeks of therapy in subjects with Active Lupus Nephritis.

Trial Details

NCT Number	NCT06406205
Lead Sponsor	Qilu Pharmaceutical Co., Ltd.
Conditions	Lupus Nephritis
Enrollment	270 participants
Start Date	2023-12-25
Primary Completion	2027-06 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2024-05-09